Contact Information
| Organisation | AstraZeneca |
|---|---|
| About | Dawn has nineteen years of pharmaceutical industry experience with a focus on and passion for the Medical Affairs function. She spent 14 years in the US market in various roles within Medical Affairs focused on operational excellence. In 2012, she helped establish the Global Medical Excellence function and then went to Japan for three years to establish the Medical Excellence function in that emerging market. Much of her experience has centered around driving an increase in the contribution and value that Medical Affairs brings to the business through strategic planning, metrics, capability development and communication strategies. In her role as PaCe Excellence Director, Dawn is responsible for the strategic direction and leadership of the capability programs to elevate patient insight and engagement skills to help teams effectively understand patient needs and co-create solutions with patients. She also facilitates enterprise-level collaborations to develop robust patient-oriented risk management and governance frameworks. |
Patient Pledge
Individual pledge to Patients is a demonstration unifying the whole research community with the same approach of a personal commitment to work with patients for patients. Taking the Pledge to Patients means looking at your everyday activities and asking, “is the patient perspective clearly addressed in everything that I do?” Taking the Pledge to Patients means committing to simple, measurable and sustainable patient-centred principles, that will lead to better and more meaningful patient and healthcare outcomes.
Making a Pledge to Patients involves commitment to 3 guiding principles: listening to patients, co-creating strategies and solutions with patients, and communicating openly and clearly with patients. Are you ready to commit?
Yes, I commit!Listen
-
I will talk to my family member with ovarian cancer in the next month to understand more about her experience as a patient expert and what she has appreciated/not appreciated about her various engagements with industry.
Work in progress
Co-create
-
As a Patient Centricity Excellence Director in the pharma industry, I will co-create with patients when building capability and training programs on how to best work with patients.
Work in progress
Communicate
-
When I co-create capability and training programs with patients, I will communicate the impact of these programs with them after they are delivered.
Work in progress
